Actions of epoxyeicosatrienoic acid on large-conductance Ca(2+)-activated K(+) channels in pituitary GH(3) cells.
Epoxyeicosatrienoic acids (EETs), a family of cytochrome P450 epoxygenase metabolites of arachidonic acid, are believed to have an autocrine or paracrine role in the regulation of neurons or neuroendocrine cells. The effects of 14,15-EET on ionic currents were investigated in rat pituitary GH(3) cells. In the whole-cell configuration, 14,15-EET (3 microM) reversibly increased the amplitude of the Ca(2+)-activated K(+) current (I(K(Ca))). The 14, 15-EET-induced increase in I(K(Ca)) was unaffected in the presence of 10 microM thyrotropin-releasing hormone externally or 10 microM inositol trisphosphate in the recording pipette. In cells preincubated with pertussis toxin or herbimycin A, the 14, 15-EET-induced increase in I(K(Ca)) was also not changed. In the inside-out configuration, 14,15-EET applied intracellularly did not change single-channel conductance, but did increase the opening probability of large-conductance Ca(2+)-activated K(+) (BK(Ca)) channels. 14,15-EET (3 microM) shifted the activation curve of BK(Ca) channels to less positive membrane potential by approximately 15 mV. The change in the kinetic behavior of BK(Ca) channels caused by 14,15-EET is explained by a lengthening of open and a shortening of closed times. 14,15-EET increased the activity of BK(Ca) channels in a concentration-dependent manner with an EC(50) value of 1 microM. However, 14,15-EET did not affect the Ca(2+) sensitivity of BK(Ca) channels. The present study indicates that 14,15-EET is an opener of BK(Ca) channels in GH(3) cells and that the stimulatory effect of 14, 15-EET on these channels may, at least in part, contribute to the underlying cellular mechanisms by which EETs affect neuronal or neuroendocrine function.
Wu
S N
SN
Department of Medical Education and Research, Veterans General Hospital-Kaohsiung, Kaohsiung City, Taiwan. snwu@isca.vghks.gov.tw
Li
H F
HF
Chiang
H T
HT
D015126:8,11,14-Eicosatrienoic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D007700:Kinetics; D051036:Large-Conductance Calcium-Activated Potassium Channels; D037342:Pertussis Toxin; D010902:Pituitary Gland / Q000166:cytology / Q000187:drug effects*; D015221:Potassium Channels / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism; D024681:Potassium Channels, Calcium-Activated; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D051381:Rats; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D051036:Large-Conductance Calcium-Activated Potassium Channels; D015221:Potassium Channels; D024681:Potassium Channels, Calcium-Activated; D010566:Virulence Factors, Bordetella; C046782:14,15-epoxy-5,8,11-eicosatrienoic acid; D037342:Pertussis Toxin; D011505:Protein-Tyrosine Kinases; D015126:8,11,14-Eicosatrienoic Acid; D002118:Calcium